Search results
Found 30047 matches for
Macrophages treated with the short-chain fatty acid butyrate – a by-product of dietary fibre breakdown - are better equipped to fight bacteria in the gut, report researchers from the Kennedy Institute and the Translational Gastroenterology Unit. These findings could lead to new strategies to restore gut health in inflammatory bowel disease (IBD).
Norman Collisson Foundation Scholarship
Applications for this project are now closed.
Themes
OCTRU runs trials across multiple areas of medicine. Within OCTRU there are five core therapeutic areas of expertise, although trials are also undertaken outside of these areas and groups.
Meet Fiona
-
Fiona Powrie FRS
Professor of Musculoskeletal Sciences and Director of the Kennedy Institute
Find out more about
Similar stories
TCRs drive CARs
1 May 2025
Researchers have developed an innovative dual-receptor T-cell therapy that promises safer and more effective cancer treatments. This study, published in Cell, demonstrates that engineering T-cells to express both a Chimeric Antigen Receptor (CAR) and a T-cell Receptor (TCR) can improve their ability to distinguish between cancerous and healthy tissues—addressing a major challenge in current immunotherapy.